Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients

BACKGROUND: Cereblon (CRBN) is a direct target of immunomodulatory drugs (IMiDs) and is known to be sensitive and responsive to IMiD therapy. We evaluated CRBN expression in bone marrow plasma cells and analyzed whether CRBN expression was associated with multiple myeloma prognosis. Lastly, we devel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Oncol
Hoofdauteurs: Lee, Byung-Hyun, Kang, Ka-Won, Jeon, Min Ji, Yu, Eun Sang, Kim, Dae Sik, Lee, Se Ryeon, Sung, Hwa Jung, Park, Yong, Choi, Chul Won, Kim, Byung Soo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316857/
https://ncbi.nlm.nih.gov/pubmed/34336672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.687361
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items